Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 2901 - 2925 of 3127 in total

(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione

Experimental

N-acetyl-beta-D-galactosamine 6-sulfate

Experimental

N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3

Experimental

Prinomastat

Prinomastat is a synthetic hydroxamic acid derivative with potential antineoplastic activity. Prinomastat inhibits matrix metalloproteinases (MMPs) (specifically, MMP-2, 9, 13, and 14), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. As a lipophilic agent, prinomastat crosses the blood-brain barrier.
Investigational

Pinazepam

Experimental

PG-701

Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational

Valrocemide

Investigational

(S)-methoprene

Vet approved

Acetylcysteine amide

Experimental

1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide

Experimental

Vesatolimod

Vesatolimod has been used in trials studying the treatment of Hepatitis B and Chronic Hepatitis B.
Investigational

Tirilazad

Tirilazad has been used in trials studying the treatment of Spinal Cord Injury.
Investigational

Reidispongiolide C

Experimental

L-N(omega)-nitroarginine-(4R)-amino-L-proline amide

Experimental

5'-O-(L-Threonylsulfamoyl)adenosine

Experimental

N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE

Experimental

Taurochenodeoxycholic acid

Taurochenodeoxycholic acid is an experimental drug that is normally produced in the liver. Its physiologic function is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile...
Experimental

Fominoben

Fominoben is an antitussive agent.
Experimental
Withdrawn

(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid

Experimental

5-hydroxymethyl-5,6-dihydrofolic acid

Experimental

Firategrast

Firategrast has been used in trials studying the treatment of Multiple Sclerosis.
Investigational

4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide

Experimental

Firocoxib

Firocoxib is a cycooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug. It currently approved for veterinary use in dogs and horses under the brand names Equioxx and Previcox. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use...
Experimental
Vet approved

(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid

Experimental

Puromycin

Puromycin is an antibiotic that prevents bacterial protein translation. It is utilized as a selective agent in laboratory cell cultures. Puromycin is toxic to both prokaryotic and eukaryotic cells, resulting in significant cell death at appropriate doses.
Experimental
Displaying drugs 2901 - 2925 of 3127 in total